Tue Apr 18, 2023 – 10:15 am EDT
(LifeSiteNews) — Chemical abortions were more than half of all US abortions in 2020, possibly 60% or more now according to recent estimates. Federal court cases are pending in Texas and Washington relating to the validity of the FDA’s 2000 approval of the abortion drug mifepristone and the FDA’s 2016-2023 rule changes that loosened restrictions on chemical abortion procedures.
The Supreme Court is expected to make an interim ruling this week on whether or not to temporarily block the FDA’s approval of the abortion drug and/or limit its use. This would be a temporary hold (“stay” order) until those issues can be litigated more fully in the lower courts. Or the Court could allow chemical abortions to continue as usual while the lower Courts do their job.
In any case, chemical abortions may be significantly more restricted this week, or not, depending on the Supreme Court.
Here’s what you should know:
1. This case originated in a federal District Court in Texas. The Texas judge put a temporary hold on the FDA’s approval of the abortion drug mifepristone,
The remainder of this article is available in its entirety at LifeSite News
The views expressed in this news alert by the author do not directly represent that of The Official Street Preachers or its editors
